Unibest
← Back to patent-cliff list

CAS 223734-60-9

(4R,9aS)-4-((tert-butyldimethylsilyl)oxy)-8-methoxy-3-((3S)-3-((tetrahydro-2H-pyran-2-yl)oxy)octyl)-1,4,9,9a-tetrahydro-2H-cyclopenta[b]naphthalen-2-one

Codes: TREP-042

Application context (from source-drug indications)

Interstitial lung diseaseTreprostinilPulmonary hypertensionTreprostinilPulmonary arterial hypertensionTreprostinilIdiopathic pulmonary fibrosisTreprostinilPulmonary fibrosisTreprostinilIdiopathic pulmonary arterial hypertensionTreprostinil

Source drugs (routes using this intermediate)

DrugTierExpiry
TreprostinilTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

TreprostinilOptimised routesteps: 15total yield: 76 mg

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site2H-Benz[f]inden-2-one, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3a,4,9-tetrahydro-5-methoxy-1-[(3S)-3-[(tetrahydro-2H-pyran-2-yl)oxy]octyl]-, (3aS,9R)-
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.